191 related articles for article (PubMed ID: 9551719)
21. alpha2A-adrenoceptor antagonism increases insulin secretion and synergistically augments the insulinotropic effect of glibenclamide in mice.
Fagerholm V; Scheinin M; Haaparanta M
Br J Pharmacol; 2008 Jul; 154(6):1287-96. PubMed ID: 18493247
[TBL] [Abstract][Full Text] [Related]
22. A new, simple and robust radioligand binding method used to determine kinetic off-rate constants for unlabeled ligands. Application at α2A- and α2C-adrenoceptors.
Uhlén S; Schiöth HB; Jahnsen JA
Eur J Pharmacol; 2016 Oct; 788():113-121. PubMed ID: 27318322
[TBL] [Abstract][Full Text] [Related]
23. Non-adrenergic binding of [3H]atipamezole in rat kidney--regional distribution and comparison to alpha2-adrenoceptors.
Sjöholm B; Lähdesmäki J; Pyykkö K; Hillilä M; Scheinin M
Br J Pharmacol; 1999 Nov; 128(6):1215-22. PubMed ID: 10578134
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the binding activities of some drugs on alpha 2A, alpha 2B and alpha 2C-adrenoceptors and non-adrenergic imidazoline sites in the guinea pig.
Uhlén S; Muceniece R; Rangel N; Tiger G; Wikberg JE
Pharmacol Toxicol; 1995 Jun; 76(6):353-64. PubMed ID: 7479575
[TBL] [Abstract][Full Text] [Related]
25. Expression and function of alpha-adrenoceptors in zebrafish: drug effects, mRNA and receptor distributions.
Ruuskanen JO; Peitsaro N; Kaslin JV; Panula P; Scheinin M
J Neurochem; 2005 Sep; 94(6):1559-69. PubMed ID: 16000146
[TBL] [Abstract][Full Text] [Related]
26. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
[TBL] [Abstract][Full Text] [Related]
27. Stimulation frequency-noradrenaline release relationships examined in alpha2A-, alpha2B- and alpha2C-adrenoceptor-deficient mice.
Scheibner J; Trendelenburg AU; Hein L; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 2001 Oct; 364(4):321-8. PubMed ID: 11683519
[TBL] [Abstract][Full Text] [Related]
28. Yohimbine dimers exhibiting selectivity for the human alpha 2C-adrenoceptor subtype.
Lalchandani SG; Lei L; Zheng W; Suni MM; Moore BM; Liggett SB; Miller DD; Feller DR
J Pharmacol Exp Ther; 2002 Dec; 303(3):979-84. PubMed ID: 12438517
[TBL] [Abstract][Full Text] [Related]
29. Reduced expression of alpha2C-adrenoceptors in rat striatum following antisense oligodeoxynucleotide infusion.
Lu L; Ordway GA
Brain Res Mol Brain Res; 1997 Jul; 47(1-2):267-74. PubMed ID: 9221925
[TBL] [Abstract][Full Text] [Related]
30. Centhaquin antinociception in mice is mediated by α2A- and α2B- but not α2C-adrenoceptors.
Bhalla S; Ali I; Andurkar SV; Gulati A
Eur J Pharmacol; 2013 Sep; 715(1-3):328-36. PubMed ID: 23712005
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo approaches to the characterization of the alpha2-adrenoceptor.
Hudson AL; Robinson ES; Lalies MD; Tyacke RJ; Jackson HC; Nutt DJ
J Auton Pharmacol; 1999 Dec; 19(6):311-20. PubMed ID: 10961736
[TBL] [Abstract][Full Text] [Related]
32. Expression of functional alpha2-adrenergic receptor subtypes in human corpus cavernosum and in cultured trabecular smooth muscle cells.
Traish AM; Moreland RB; Huang YH; Goldstein I
Recept Signal Transduct; 1997; 7(1):55-67. PubMed ID: 9285531
[TBL] [Abstract][Full Text] [Related]
33. alpha2C adrenoceptors inhibit adenylyl cyclase in mouse striatum: potential activation by dopamine.
Zhang W; Klimek V; Farley JT; Zhu MY; Ordway GA
J Pharmacol Exp Ther; 1999 Jun; 289(3):1286-92. PubMed ID: 10336518
[TBL] [Abstract][Full Text] [Related]
34. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
Hussain JF; Kendall DA; Wilson VG
Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
[TBL] [Abstract][Full Text] [Related]
35. Inverse agonism at alpha(2)-adrenoceptors in native tissue.
Murrin LC; Gerety ME; Happe HK; Bylund DB
Eur J Pharmacol; 2000 Jun; 398(2):185-91. PubMed ID: 10854829
[TBL] [Abstract][Full Text] [Related]
36. Antagonists that differentiate between alpha 2A-and alpha 2D-adrenoceptors.
Trendelenburg AU; Wahl CA; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):245-9. PubMed ID: 8692278
[TBL] [Abstract][Full Text] [Related]
37. A comparative study of postsynaptic alpha2-adrenoceptors of the dog mesenteric and rat femoral veins.
Paiva MQ; Morato M; Moura D; Guimarães S
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):165-70. PubMed ID: 10494886
[TBL] [Abstract][Full Text] [Related]
38. The C-terminal half of the α2C-adrenoceptor determines the receptor's membrane expression level and drug selectivity.
Jahnsen JA; Uhlén S
Naunyn Schmiedebergs Arch Pharmacol; 2013 Dec; 386(12):1031-40. PubMed ID: 23868076
[TBL] [Abstract][Full Text] [Related]
39. Alpha2-adrenoceptors modulating neuronal serotonin release: a study in alpha2-adrenoceptor subtype-deficient mice.
Scheibner J; Trendelenburg AU; Hein L; Starke K
Br J Pharmacol; 2001 Feb; 132(4):925-33. PubMed ID: 11181434
[TBL] [Abstract][Full Text] [Related]
40. Chronic fluoxetine reverses the effects of chronic corticosterone treatment on α
Horrillo I; Ortega JE; Diez-Alarcia R; Urigüen L; Meana JJ
Neuropharmacology; 2019 Nov; 158():107731. PubMed ID: 31376424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
